Yiling Pharmaceutical's wholly-owned subsidiary, Yiling Wanzhou International Pharmaceutical Co., Ltd., has received a drug registration certificate from China's National Medical Products Administration for its Tadalafil tablets. This approval grants the subsidiary the qualification to sell the drug in the domestic market. The company stated that this development is not expected to have a significant impact on its current operating performance. AI
RANK_REASON This is a product approval for a pharmaceutical subsidiary, not a core AI release or significant industry event.
- National Medical Products Administration
- Tadalafil tablets
- Yiling Pharmaceutical
- Yiling Wanzhou International Pharmaceutical Co., Ltd.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
